| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.06 |